|
Report No. : |
339397 |
|
Report Date : |
09.09.2015 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIO PASTEUR S.A. |
|
|
|
|
Registered Office : |
Calle Ignacio Serrano 568, Concepción |
|
|
|
|
Country : |
Chile |
|
|
|
|
Date of Incorporation : |
1976 |
|
|
|
|
Legal Form : |
Sociedad Anónima |
|
|
|
|
Line of Business : |
Manufacture of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
300 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 100 000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Chile |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CHILE - ECONOMIC OVERVIEW
Chile has a market-oriented economy characterized by a high level
of foreign trade and a reputation for strong financial institutions and sound
policy that have given it the strongest sovereign bond rating in South America.
Exports of goods and services account for approximately one-third of GDP, with
commodities making up some three-quarters of total exports. Copper alone
provides 19% of government revenue. From 2003 through 2013, real growth
averaged almost 5% per year, despite the slight contraction in 2009 that
resulted from the global financial crisis. Growth slowed to 4.2% in 2014. Chile
deepened its longstanding commitment to trade liberalization with the signing
of a free trade agreement with the US, which took effect on 1 January 2004.
Chile has 22 trade agreements covering 60 countries including agreements with
the European Union, Mercosur, China, India, South Korea, and Mexico. Chile has
joined the United States and 10 other countries in negotiating the
Trans-Pacific Partnership trade agreement. The Chilean Government has generally
followed a countercyclical fiscal policy, accumulating surpluses in sovereign
wealth funds during periods of high copper prices and economic growth, and
generally allowing deficit spending only during periods of low copper prices
and growth. As of 31 December 2012, those sovereign wealth funds - kept mostly
outside the country and separate from Central Bank reserves - amounted to more
than $20.9 billion. Chile used these funds to finance fiscal stimulus packages
during the 2009 economic downturn. In May 2010 Chile signed the OECD Convention,
becoming the first South American country to join the OECD. In 2014, President
Michelle BACHELET introduced tax reforms aimed at delivering her campaign
promise to fight inequality and to provide access to education and health care.
The reforms are expected to generate additional tax revenues equal to 3% of
Chile’s GDP, mostly by increasing corporate tax rates to OECD averages.
|
Source
: CIA |
STATUTORY INFORMATION
|
|
|
Legal Name: |
LABORATORIO PASTEUR S.A. |
|
Trade Name: |
Laboratorio Pasteur |
|
RUT: |
87674400-7 |
|
Date Created: |
1976 |
|
Date Incorporated: |
01/01/1993 |
|
Legal Address: |
Calle Ignacio
Serrano 568 |
|
Operative Address: |
Calle Ignacio
Serrano 568 |
|
Telephone: |
56 2 2264 2893 |
|
Fax: |
56 2 2264 2893 |
|
Legal Form: |
Sociedad Anónima |
|
Email: |
|
|
Registered in: |
Chile |
|
Website: |
|
|
Contact: |
Roberto Vega Fernàndez |
|
Staff: |
300 |
|
Activity: |
Pharmaceutical Manufacturing Industry |
|
|
|
|
BANKS |
Banco Santander Río S.A. |
|
|
|
|
|
The company does not disclose its
banking information |
|
History: |
|
|
|
The company dates back to 1976, when the
Vega Fernandez family acquired company, inheritors of the Humberto Vega Rojas
& Sons partnership. |
|
|
|
PRINCIPAL ACTIVITY
|
|
|
|
Laboratorio Pasteur S.A. is an industrial company
dedicated to the manufacture of pharmaceutical products. |
|
Products/Services description: |
Medical promotion and commercialization of
pediatrics, gynecology, urology, cardiology, general medicine and internal
medicine. |
|
Brands: |
Some of ots various
brands: |
|
Representatives of: |
YVES PONROY |
|
Sales are: |
Wholesale |
|
Clients: |
Farmacia
Veterinaria SA |
|
Suppliers: |
Procaps S.A. |
|
Operations area: |
National
and International |
|
The company imports from |
Colombia |
|
The company exports to |
No exports |
|
The subject employs |
300 employees |
|
Payments: |
No Complaints |
|
|
|
LOCATION
|
|
|
Headquarters : |
Calle Ignacio
Serrano 568 |
|
Branches: |
Calle Gral Calderon 125, Providencia, Santiago,
Región Metropolitana, Chile |
|
|
|
GROUP STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NO |
|
Capital |
NA |
|
Shareholders: |
This is a private company managed and owned
by the Vega Fernandez family. |
|
Management: |
Javier Vega, Commercial Manager |
|
Related Companies: |
No related companies |
|
|
|
FINANCIAL INFORMATION
|
|
|
|
There are no financial connected to the
subject. The following information has been provided by our private sources. |
|
|
|
|
USD 2014 |
|
|
Revenue |
17
371 000 |
|
Net Income |
456 000 |
|
Total Equity |
123 242 000 |
|
|
|
|
Imports in US$ |
|
|
Year |
Total |
|
2013 |
US$ 1,704,321 |
|
2012 |
US$ 1,862,153 |
|
2011 |
US$ 2,221,939 |
|
2010 |
US$ 2,376,939 |
|
2009 |
US$ 2,288,196 |
|
2008 |
US$ 2,062,974 |
|
2007 |
US$ 665,750 |
|
|
|
|
|
|
|
Exports in US$ |
|
|
Year |
Total |
|
2013 |
US$ 286,633 |
|
2012 |
US$ 95,538 |
|
2011 |
US$ 31,966 |
|
2010 |
US$ 258,616 |
|
2009 |
US$ 100,571 |
|
2008 |
US$ 321,457 |
|
2007 |
US$ 24,410 |
|
|
|
LEGAL FILINGS
|
|
|
|
There are no legal records connected to the
subject |
|
|
|
REVIEW
|
|
|
Maximum Credit Provided |
USD 100 000 |
|
|
|
SUMMARY
|
|
|
|
Laboratorio Pasteur S.A. is an industrial
company dedicated to the manufacture of pharmaceutical products. The company has more than 35 years of
experience in the market; it is well established in the industry and shows no
negative records. Its profitability is positive. |
|
|
|
RISK INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
No Complaints |
|
CASH FLOW |
Normal |
|
SUGGESTED CREDIT LINE |
USD 100 000 |
|
STATUS |
Active |
|
|
|
|
INTERVIEW |
|
|
NAME |
Gabriela |
|
POSITION |
Administrative |
|
COMMENTS |
She confirmed address, branch, manager,
ownership, activity. She refused to confirm more information alleging she had
no such data. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.60 |
|
|
1 |
Rs.102.30 |
|
Euro |
1 |
Rs.74.61 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.